Cipla Limited (CIPLA.BO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Umang Vohra B.E., M.B.A.
|
MD, Global CEO & Executive Director | 238.9M | -- | 1971 |
|
Mr. Pradeep Bhadauria
|
President & Global Chief Scientific Officer | -- | -- | -- |
|
Mr. Ashish Adukia
|
Global Chief Financial Officer | -- | -- | -- |
|
Mr. Achin Gupta
|
Global Chief Operating Officer | -- | -- | 1976 |
|
Mr. Dinesh Ramniranjan Jain
|
Senior VP & Head of Corporate Finance | -- | -- | -- |
|
Ms. Sneha Hiranandani B Com
|
Chief Information Officer | -- | -- | -- |
|
Ms. Diksha Maheshwari
|
Head of Investor Relations | -- | -- | -- |
|
Mr. Rajendra Kumar Chopra
|
Compliance Officer & Company Secretary | 15.3M | -- | -- |
|
A. S. Kumar
|
Global General Counsel | -- | -- | -- |
|
Ms. Heena Kanal
|
Senior Vice-President of Corporate Communications | -- | -- | -- |
Cipla Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 30,313
Description
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Corporate Governance
Upcoming Events
January 21, 2027 at 10:00 AM UTC
Cipla Limited Earnings Date
Recent Events
June 27, 2025 at 12:00 AM UTC
Ex-Dividend Date
